Bionanoprobes to study particle-cell interactions

Journal of Nanoscience and Nanotechnology

Volumn 9, Issue 5, 2009, Pages 3239-3245

  Fillafer, Christian ^a   Friedi, Daniela S ^a   Ilyes, Adina K ^a   Wirth, Michael ^a   Gabor, Franz ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Albumin; BODI PY; Fluorescence.; Nanoparticle; Stability

Indexed keywords

ALBUMIN; BODI PY; CACO-2 CELLS; CELL CULTURE MEDIUMS; CELL INTERACTION; DISPERSANTS; FINE TUNING; FLUORESCENT MARKERS; FUNCTIONALISATION; HIGH SENSITIVITY; HUMAN SERUM ALBUMINS; HYDROPHILIC PARTICLES; INTERACTION CHARACTERISTICS; MEAN PARTICLE SIZE; MODEL SYSTEM; NANO-DROPLETS; NO RELEASE; PARTICLE SURFACE; POLY(D ,L-LACTIDE-CO-GLYCOLIDE); QUENCHING EFFECT; RESEARCH REPORTS; WITHOUT AGGLOMERATION;

AGGLOMERATION; ANIMAL CELL CULTURE; BIOLOGICAL SYSTEMS; CELL CULTURE; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; NANOPARTICLES; ORGANIC POLYMERS; QUENCHING; SUSPENSIONS (FLUIDS); SYSTEM STABILITY; ZETA POTENTIAL;

PARTICLE SIZE ANALYSIS;

4,4 DIFLUORO 4 BORA 3A,4A DIAZA S INDACENE; 4,4-DIFLUORO-4-BORA-3A,4A-DIAZA-S-INDACENE; BORON DERIVATIVE; LACTIC ACID; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; SERUM ALBUMIN;

ARTICLE; CELL COMMUNICATION; CELL STRAIN CACO 2; CHEMISTRY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; PARTICLE SIZE; SYNTHESIS; TEMPERATURE;

BORON COMPOUNDS; CACO-2 CELLS; CELL COMMUNICATION; FLOW CYTOMETRY; HUMANS; LACTIC ACID; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SERUM ALBUMIN; TEMPERATURE;

EID: 67549088420     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2009.226     Document Type: Article

References (16)

1. S. K. Lai, K. Hida, S. T. Man, C. Chen, C. Machamer, T. A. Schroer, and J. Hanes, Biomaterials 28, 2876 (2007).
2. J. Rejman, V. Oberle, I. S. Zuhorn, and D. Hoekstra, Biochem. J.377, 159 (2004).
3. G.Oberdörster, E. Oberdörster, and J. Oberdörster, Environ. Health Perspect. 113, 823 (2005).
4. O. C. Farokhzad and R. Langer, Adv. Drug Delivery Rev. 58, 1456 (2006).
5. D. Peer, J. M. Karp, S. Hong, 0. C. Farokhzad, R. Margalit, and R. Langer, Nat.Nanotechnol. 2, 751 (2007).
6. N. S. White and R. J. Errington, Adv. Drug Delivery Rev. 57, 17 (2005).
7. F. Delie and W. Rubas, Crit. Rev. Therapeutic Drug Carrier Systems 14, 221 (1997).
8. A. Weissenboeck, E. Bogner, M. Wirth, and F. Gabor, Pharmn. Res.21, 1917 (2004).
9. H. Suh, B. Jeong, F. Liu, and S. W. Kim, Pharmn. Res. 15, 1495 (1998).
10. B. Weiss, U. F. Schaefer, J. Zapp, A. Lamprecht, A. Stallmach, and C.-M. Lehr, J. Nanosci. Nanotech. 6, 3048 (2006).
11. G. Tosi, L. Costantino, F. Rivasi, B. Ruozi, E. Leo, A. V. Vergoni, R. Tacchi, A. Bertolini, M. A. Vandelli, and F. Fomi, J. Controlled Release 122, 1 (2007).
12. J. A. Baker and J. C. Berg, Langmuir 4, 1055 (1988).
13. K. Langer, S. Baithasar, V. Vogel, N. Dinauer, H.Von Briesen, and 0. Schubert, Int. J. Pharm. 257, 169 (2003).
14. R.P. Haugland, The Handbook-A Guide to Fluorescent Probes and Labeling Technologies, 10th edn., Invitrogen Corp., USA (2005), p.4.
15. C.Fillafer, D. S. Friedl, M. Wirth, and F Gabor, Small 4,627 (2008).
16. P.Pietzonka, B. Rothen-Rutishauser, P. Langguth, H.WunderliAllenspach, E. Walter, and H. P. Merkle, Pharm. Res.19, 595 (2002).